Cleared Traditional

K984631 - BDPROBETEC ET CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE AMPLIFIED DNA ASSAY (FDA 510(k) Clearance)

Nov 1999
Decision
309d
Days
Class 2
Risk

K984631 is an FDA 510(k) clearance for the BDPROBETEC ET CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE AMPLIFIED DNA ASSAY. This device is classified as a Dna-reagents, Neisseria (Class II - Special Controls, product code LSL).

Submitted by Becton Dickinson Microbiology Systems (Sparks, US). The FDA issued a Cleared decision on November 4, 1999, 309 days after receiving the submission on December 30, 1998.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3390.

Submission Details

510(k) Number K984631 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 1998
Decision Date November 04, 1999
Days to Decision 309 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LSL — Dna-reagents, Neisseria
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3390

Similar Devices — LSL Dna-reagents, Neisseria

All 44
Aptima Neisseria gonorrhoeae Assay
K231329 · Hologic, Inc. · Jan 2024
Aptima Combo 2 Assay (Panther System)
K180681 · Hologic, Inc. · Jun 2018
cobas CT/NG for use on cobas 6800/8800 systems
K173887 · Roche Molecular Systems, Inc. · Mar 2018
Xpert CT/NG
K173840 · Cepheid · Mar 2018
cobas? CT/NG v2.0 Test
K163184 · Roche Molecular Systems, Inc. · Feb 2017
BD PROBETEC NEISSERIA GONORRHOEAE (GC) QX AMPLIFIED DNA ASSAY
K140448 · Becton, Dickinson & CO · May 2014